Senior Director, COS Nordic & Managing Director, COS DACH

Randi holds a MSc in Pharmacy and joined KLIFO in January 2021. She has more than 20 years of experience within people leadership, drug development and clinical operations excellence and has been with large, mid-sized and small pharma companies as Director for Trial Operations and Business Support.

During her career, Randi has been operational responsible for planning and execution of global clinical development programs from early stage to the post-approval phase.

Direct/mobile: + 45 44 778 704
Email: moc.ofilk@keabhar.idnar

Dr. Christoph Kapitza joined KLIFO on 1 August 2022 and brings more than 25 years of research experience in the development of drugs, devices and drug-device combination products. He has a proven track record of successfully executing drug development strategies and has held several leadership positions in the pharma industry. Dr. Kapitza has been Principle Investigator in approx. 90 early and later phase studies, and he has been a consultant in relation to clinical development plans (phase I through to post-marketing studies) for several top global pharma companies.

Direct/mobile: +49 160 765 1092
Email: moc.ofilk@aztipaK.hpotsirhC